{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:31:28Z","timestamp":1788521488812,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013398","name":"Innlandet Hospital Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013398","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jtemb.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T17:46:47Z","timestamp":1418665607000},"page":"183-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Iron and copper in progressive demyelination \u2013 New lessons from Skogholt's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Klaus Thanke","family":"Aspli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Peder","family":"Flaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per M.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Holm\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon H.","family":"Skogholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-9687","authenticated-orcid":false,"given":"Jan","family":"Aaseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtemb.2014.12.002_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1750-3639.1996.tb00854.x","article-title":"Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis","volume":"6","author":"Lucchinetti","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/153537020623100906","article-title":"Metals in motor neuron diseases","volume":"231","author":"Roos","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0015","first-page":"731","article-title":"The role of metals in neurodegenerative diseases","volume":"46","author":"Sayre","year":"2000","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200216050-00006","article-title":"The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications","volume":"16","author":"Perry","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0361-9230(03)00182-5","article-title":"The role of metals in neurodegenerative processes: aluminum, manganese, and zinc","volume":"62","author":"Zatta","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0300-483X(87)90138-7","article-title":"Alterations of lipid synthesis in the normal and dysmyelinating trembler mouse sciatic nerve by heavy metals (Hg, Pb, Mn, Cu, Ni)","volume":"46","author":"Cloez","year":"1987","journal-title":"Toxicology"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/BTER:93:1-3:1","article-title":"Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis","volume":"93","author":"Melo","year":"2003","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(87)90827-0","article-title":"Raised cerebrospinal-fluid copper concentration in Parkinson's disease","volume":"2","author":"Pall","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0045","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases","author":"Dusek","year":"2014","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.spen.2006.08.008","article-title":"Iron: a new target for pharmacological intervention in neurodegenerative diseases","volume":"13","author":"Whitnall","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0361-9230(01)00454-3","article-title":"Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases","volume":"55","author":"Strausak","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12011-012-9547-x","article-title":"Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis","volume":"151","author":"Roos","year":"2013","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/pri.2.1.6297","article-title":"Ceruloplasmin fragmentation is implicated in \u2018free\u2019 copper deregulation of Alzheimer's disease","volume":"2","author":"Squitti","year":"2008","journal-title":"Prion"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in Alzheimer's disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.24136","article-title":"Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease","volume":"75","author":"Squitti","year":"2014","journal-title":"Ann Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.jtemb.2014.12.002_bib0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-4159.2011.07500.x","article-title":"The role of metallobiology and amyloid-beta peptides in Alzheimer's disease","volume":"120","author":"Roberts","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2014.01.009","article-title":"The complexities of the pathology\u2013pathogenesis relationship in Alzheimer disease","volume":"88","author":"Castellani","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0095","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/ic4031377","article-title":"Site-specific copper-catalyzed oxidation of alpha-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease","volume":"53","author":"Miotto","year":"2014","journal-title":"Inorg Chem"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.08.042","article-title":"Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease","volume":"266","author":"Gellein","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.55.11.1467","article-title":"Progressive central and peripheral demyelinating disease of adult onset in a Norwegian family","volume":"55","author":"Hagen","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1651-2227.1981.tb05536.x","article-title":"Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in \u2018normal\u2019 subjects from the age of 6 months to 30 years","volume":"70","author":"Eeg-Olofsson","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbagen.2011.10.016","article-title":"Functional roles of transferrin in the brain","volume":"1820","author":"Leitner","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mri.2012.11.011","article-title":"Visualizing iron in multiple sclerosis","volume":"31","author":"Bagnato","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10072-012-1269-5","article-title":"Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology","volume":"34","author":"Comi","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0130","doi-asserted-by":"crossref","first-page":"e57573","DOI":"10.1371\/journal.pone.0057573","article-title":"Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions","volume":"8","author":"Mehta","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0135","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/jcbfm.2009.180","article-title":"Anomalous venous blood flow and iron deposition in multiple sclerosis","volume":"29","author":"Singh","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jcbfm.2013.31","article-title":"What went wrong? The flawed concept of cerebrospinal venous insufficiency","volume":"33","author":"Valdueza","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.12120863","article-title":"Multiple sclerosis: validation of MR imaging for quantification and detection of iron","volume":"267","author":"Walsh","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1258\/jrsm.99.11.589","article-title":"The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis","volume":"99","author":"Zamboni","year":"2006","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.0909737107","article-title":"Homocystamides promote free-radical and oxidative damage to proteins","volume":"107","author":"Sibrian-Vazquez","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0160","doi-asserted-by":"crossref","first-page":"797S","DOI":"10.1093\/ajcn\/63.5.797","article-title":"Copper biochemistry and molecular biology","volume":"63","author":"Linder","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0165","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0753-3322(03)00012-X","article-title":"Trace elements in human physiology and pathology. Copper","volume":"57","author":"Tapiero","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2008.10.056","article-title":"Copper transport to the brain by the blood\u2013brain barrier and blood\u2013CSF barrier","volume":"1248","author":"Choi","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0041-008X(03)00251-5","article-title":"Brain barrier systems: a new frontier in metal neurotoxicological research","volume":"192","author":"Zheng","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1097-0029(20010101)52:1<89::AID-JEMT11>3.0.CO;2-2","article-title":"Toxicology of choroid plexus: special reference to metal-induced neurotoxicities","volume":"52","author":"Zheng","year":"2001","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/157488910793362395","article-title":"Copper status abnormalities and how to measure them in neurodegenerative disorders","volume":"5","author":"Siotto","year":"2010","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/174329210X12650506623087","article-title":"Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid","volume":"15","author":"Spasojevic","year":"2010","journal-title":"Redox Rep"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10715760100300391","article-title":"Quinolinic acid\u2013iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction","volume":"34","author":"Platenik","year":"2001","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/bss0610127","article-title":"Therapeutic iron chelators and their potential side-effects","volume":"61","author":"Singh","year":"1995","journal-title":"Biochem Soc Symp"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0887-8994(88)90022-7","article-title":"Does CSF copper level in Wilson disease reflect copper accumulation in the brain?","volume":"4","author":"Kodama","year":"1988","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2006.07.017","article-title":"Wilson's disease: a clinico-neuropathological autopsy study","volume":"15","author":"Meenakshi-Sundaram","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/WNL.41.2_Part_1.272","article-title":"Comparison of functional and structural brain disturbances in Wilson's disease","volume":"41","author":"Grimm","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11011-005-7910-8","article-title":"Wilson disease","volume":"20","author":"Kitzberger","year":"2005","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0230","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1196\/annals.1306.009","article-title":"Manganese neurotoxicity","volume":"1012","author":"Dobson","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","article-title":"The role of copper in neurodegenerative disease","volume":"6","author":"Waggoner","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0250","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4065\/81.10.1371","article-title":"Copper deficiency myelopathy (human swayback)","volume":"81","author":"Kumar","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0255","first-page":"23","article-title":"Myelin, copper, and the cuprizone model of schizophrenia","volume":"3","author":"Herring","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","article-title":"Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice","volume":"92","author":"Hiremath","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2007.12.003","article-title":"TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model","volume":"194","author":"Iocca","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0280","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0463.2012.02882.x","article-title":"The cuprizone model: regional heterogeneity of pathology","volume":"120","author":"Wergeland","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2009.03.011","article-title":"Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia","volume":"1270","author":"Yang","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0290","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s00018-005-5073-8","article-title":"Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment","volume":"62","author":"Zatta","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0295","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2011.09.004","article-title":"Peroxidation of lipoproteins in multiple sclerosis","volume":"311","author":"Ferretti","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0305","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbadis.2010.06.011","article-title":"Radical changes in multiple sclerosis pathogenesis","volume":"1812","author":"van Horssen","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0310","doi-asserted-by":"crossref","first-page":"961863","DOI":"10.1155\/2014\/961863","article-title":"Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment","volume":"2014","author":"Gironi","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0315","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12011-014-9956-0","article-title":"Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis","volume":"158","author":"Yousefi","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2014.03.014","article-title":"Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis","volume":"271","author":"Rosjo","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtemb.2014.12.002_bib0325","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2174\/092986712800609689","article-title":"Chelating agents for neurodegenerative diseases","volume":"19","author":"Ward","year":"2012","journal-title":"Curr Med Chem"}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X14002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X14002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:06:38Z","timestamp":1747188398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X14002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":65,"alternative-id":["S0946672X14002533"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2014.12.002","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron and copper in progressive demyelination \u2013 New lessons from Skogholt's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}